Facing Pressure Over Price Hikes, EpiPen Manufacturer Says It Will Distribute A Generic Version

After complaints over five price hikes since 2009, Mylan, the manufacturer of EpiPen, the rapid response allergy shot is introducing a generic version of the drug.

The pharmaceutical company said the alternate drug will be released in several weeks for $300 for a two-pack of dosages, about half the price of the current drug.

Here & Now's Jeremy Hobson speaks with Jill Schlesinger of CBS News, about the allergy injection pen uproar.

Jill Schlesinger, CBS News business analyst and host of "Jill on Money." She tweets @jillonmoney.